HDAC6

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

INHIBITING HISTONE DEACETYLASE 6 (HDAC6)
EP 4504191 A4Applicant: EIKONIZO THERAPEUTICS INCPriority: 2022
CN
EP
US
WO
11 publications
2-ISOINDOL-1,3,4-OXADIAZOLE DERIVATIVES USEFUL AS HDAC6 INHIBITORS
EP 4034536 A1Applicant: TAKEDA PHARMACEUTICALS COPriority: 2019
CN
EP
US
WO
9 publications
HDAC6 INHIBITORS AND IMAGING AGENTS
EP 4397656 A2Applicant: MASSACHUSETTS GEN HOSPITALPriority: 2017
CN
EP
US
7 publications
3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as HDAC6 inhibitors
US 12522598 B2Applicant: ORYZON GENOMICS SAPriority: 2019
CN
EP
US
WO
6 publications
HDAC6 INHIBITORS AND USES THEREOF
- EP 4003319 A4
  Applicant: EIKONIZO THERAPEUTICS INCPriority: 2019
  CN
  EP
  US
  WO
  6 publications
- US 2024174616 A1
  Applicant: EIKONIZO THERAPEUTICS INCPriority: 2021
  US
  WO
  4 publications
- US 9586973 B2
  Applicant: UNIV GENTPriority: 2015
  US
- US 20250179065 A1
  Applicant: EIKONIZO THERAPEUTICS INCPriority: 2023
  US
A COMBINATION COMPRISING A SPECIFIC HDAC6 INHIBITOR AND AT LEAST ONE CTLA4 CHECKPOINT INHIBITOR
EP 4326259 A1Applicant: ITALFARMACO SPAPriority: 2021
CN
EP
US
WO
5 publications
2-FLUOROALKYL-1,3,4-OXADIAZOL-5-YL-THIAZOL, HDAC6 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISEASE AND HFPEF
EP 4333841 A1Applicant: TENAYA THERAPEUTICS INCPriority: 2021
EP
US
WO
5 publications
QUINAZOLINE DERIVATIVES USEFUL AS SELECTIVE HDAC6 INHIBITORS
EP 4161908 A1Applicant: ANNJI PHARM CO LTDPriority: 2020
CN
EP
US
WO
4 publications
NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS
US 2023286970 A1Applicant: ITALFARMACO SPAPriority: 2020
CN
EP
US
WO
4 publications
DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS
EP 4568949 A1Applicant: ITALFARMACO SPAPriority: 2022
CN
EP
US
WO
4 publications

Drugs

HDAC6

Patents

HDAC6 INHIBITORS AND USES THEREOF